Centre Hospitalier Universitaire de Bordeaux

Futó vizsgálatok

• Toboroz

  Axitinib and Oral Metronomic Etoposide for Pediatric Children and AYA Refractory/Relapsing Medulloblastoma and Ependymoma

  NCT06485908· 1/2. fázis· Assistance Publique Hopitaux De Marseille· Forrás

• Még nem toboroz

  The Evaluation of User Experience With FARAVIEW™ Technology of the OPAL HDx™ Mapping System When Used With the FARAWAVE NAV™ ULTRA Pulsed Field Ablation Catheter in the Treatment of Atrial Fibrillation

  NCT07925359· Boston Scientific Corporation· Forrás

• Még nem toboroz

  What is the Role of the Exposome in Pulmonary Hypertension

  NCT07172334· Poitiers University Hospital· Forrás

• Még nem toboroz

  Safety and Efficacy of a STOPping Strategy Versus Classical Maintenance Dose of JAK Inhibitors in Deep Remission Patients With Ulcerative Colitis

  NCT07718529· 4. fázis· Assistance Publique Hopitaux De Marseille· Forrás

• Még nem toboroz

  Epcoritamab Plus Venetoclax Plus Ibrutinib in Patients With Chronic Lymphocytic Leukemia With TP53 Alterations

  NCT07738887· 2. fázis· The Lymphoma Academic Research Organisation· Forrás

• Még nem toboroz

  Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis

  NCT07441408· 3. fázis· Bristol-Myers Squibb· Forrás

• Még nem toboroz

  Analysis of histological risk factors and biomarkers in paediatric retinoblastoma

  2024-515962-15-00· 2. fázis· Institut Curie· Forrás

• Még nem toboroz

  FirST Lines of Biologics in pAtients With ulceRaTivE Colitis: a Randomised Controlled Trial

  NCT07576452· 4. fázis· University Hospital, Clermont-Ferrand· Forrás

• Még nem toboroz

  Discontinuation or Continuation of SGLT-2 Inhibitors Before Cardiac Surgery

  NCT07766109· 4. fázis· University Hospital, Toulouse· Forrás

• Még nem toboroz

  A Phase 2 trial of AGMB-447 in participants with idiopathic pulmonary fibrosis

  2026-526404-71-00· 2. fázis· Agomab Spain S.L.U.· Forrás

• Még nem toboroz

  The Aim of the Study is to Decipher the Alterations in Signalling Pathways of Skeletal Muscle Stem Cells (Satellite Cells (SCs)) in Individuals With COPD, as Well as to Examine the Effect of Exercise Training on SCs.

  NCT07923656· University Hospital, Bordeaux· Forrás

• Még nem toboroz

  Efficacy of Upadacitinib Re-induction Therapy in Patients With Ulcerative Colitis Who Lost Response to 30 mg Maintenance Dose

  NCT07700446· 4. fázis· Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives· Forrás

• Toboroz

  Study to Test Effects and Safety of RO7568282 in Early Parkinson's Disease

  NCT07781644· 2. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants with Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

  2024-518365-10-00· 3. fázis· F. Hoffmann-La Roche AG· Forrás

• Még nem toboroz

  A pivotal clinical study to investigate the safety and efficacy of efimosfermin compared with placebo in adult participants with compensated cirrhosis due to Metabolic dysfunction-associated steatohepatitis (MASH)

  2026-525755-82-00· 3. fázis· Glaxosmithkline Research & Development Limited· Forrás

• Még nem toboroz

  A study to investigate safety and efficacy of efimosfermin compared with placebo in adult participants with compensated cirrhosis (stage F4 fibrosis) due to MASH (NEBULA-2)

  2026-525757-37-00· 3. fázis· Glaxosmithkline Research & Development Limited· Forrás

• Még nem toboroz

  Personnalized Immunotherapy in Patients With Stage III Non-small Cell Lung Cancer

  NCT07759492· 2. fázis· Intergroupe Francophone de Cancerologie Thoracique· Forrás

• Még nem toboroz

  A Study of Lebrikizumab in Adults and Adolescents With Face and Neck Atopic Dermatitis

  NCT07873801· 3. fázis· Almirall, S.A.· Forrás

• Még nem toboroz

  Evaluation of iNstroke Aspiration Catheters for Thrombectomy: a Multi-center Prospective Study

  NCT07376447· iVascular S.L.U.· Forrás

• Még nem toboroz

  Patient-Perceived Symptoms at the Center of Obstructive Sleep Apnea (OSA) Management: Validation of the French Version of the Patient-Reported Apnea Questionnaire (PRAQ)

  NCT07836062· University Hospital, Bordeaux· Forrás

• Még nem toboroz

  Efficacy and Safety Evaluation of iNstroke 5F Aspiration Catheter for Thrombectomy

  NCT07571954· iVascular S.L.U.· Forrás

• Még nem toboroz

  SEMAFORCRANIO : Multicenter, Double-blind, Parallel, Randomized Controlled Trial of the Efficacy of Semaglutide in Hypothalamic Obesity Secondary to Craniopharyngioma in Children Aged 12 to 17 Years

  NCT07845994· 3. fázis· University Hospital, Angers· Forrás

• Még nem toboroz

  A Multicenter, Phase 2/3, Dose Range Finding Study to Evaluate the Efficacy and Safety of Atumelnant in Adults with ACTH-Dependent Cushing’s Syndrome (ADCS) Including an Open-Label Extension for Long-Term Assessment. (EQUILIBRIUM-ADCS)

  2025-522648-42-01· 2/3. fázis· Crinetics Pharmaceuticals Inc.· Forrás

• Még nem toboroz

  Study of the safety and efficacy of asciminib in pediatric and young adult participants with r/r Ph+ or ABL-class Ph-like ALL

  2025-522019-40-00· 1/2. fázis· Novartis Pharma AG· Forrás

• Még nem toboroz

  Bioavailability and Bioequivalence Study of Ziftomenib in Participants With Relapsed/Refractory AML or MDS

  NCT07929740· 1. fázis· Kura Oncology, Inc.· Forrás

• Még nem toboroz

  A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or Obesity

  NCT07861100· 3. fázis· Novo Nordisk A/S· Forrás

• Még nem toboroz

  Comparative Study of Two Vaccination Schedules for the Subunit Herpes Zoster Vaccine in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disease Patients Treated With Anti-CD20 Therapy: an Open-label Randomised Controlled Trial

  NCT07818356· 4. fázis· University Hospital, Toulouse· Forrás

• Még nem toboroz

  Phase 1/2 study to evaluate the safety, pharmacokinetics, and preliminary efficacy of SAR447998 in adults with refractory Systemic Lupus Erythematosus or Rheumatoid Arthritis

  2026-526117-28-00· 1/2. fázis· Sanofi-Aventis Recherche & Developpement· Forrás

• Toboroz

  A Study of Belzutifan in Adolescent Participants With Solid Tumors (MK-9999-01E/LIGHTBEAM-U01)

  NCT07700758· 2. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  Phase 3 Study of Investigator Choice of Chemotherapy with or without Zoldonrasib as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma

  2025-524928-21-00· 3. fázis· Revolution Medicines Inc.· Forrás

• Még nem toboroz

  Evaluate the superiority of Treatment with RAvulizumab vs plasma exchange during the first episode or a relapse In acute neuromyelitis optica (NMO) patients: a national, multicentric, randomised trial

  2026-526632-39-00· 3. fázis· Les Hopitaux Universitaires De Strasbourg· Forrás

• Meghívásos bevonás

  Open-Label Access to ATH434 for Patients Who Completed Study ATH434-201 in France

  NCT07729852· 2. fázis· Alterity Therapeutics· Forrás

• Még nem toboroz

  A Study to Investigate the Effects of Cleminorexton Compared with Placebo in the Treatment of Participants with Central Disorders of Hypersomnolence

  2026-525961-37-00· 2/3. fázis· Centessa Pharmaceuticals UK Limited· Forrás

• Még nem toboroz

  Follow-up After Oncological Resection by Endoscopic Colorectal ESD (Endoscopic Submucosal Dissection)

  NCT07871227· University Hospital, Bordeaux· Forrás

• Még nem toboroz

  Targeted And Perilesional Or Systematic Biopsy In Prostate Cancer

  NCT07296042· GCS Ramsay Santé pour l'Enseignement et la Recherche· Forrás

• Toboroz

  Bexmarilimab + Azacitidine Versus Placebo + Azacitidine in Participants With Treatment-naïve Higher-risk Myelodysplastic Syndromes

  NCT07672769· 2. fázis· Faron Pharmaceuticals Ltd· Forrás

• Még nem toboroz

  Phase I/II Trial of Dinutuximab Beta in Combination With Irinotecan and Rapamycin in Pediatric, Adolescents and Adult Patients With Relapsed/Refractory Bone Tumors.

  NCT07853105· 1/2. fázis· University Hospital, Strasbourg, France· Forrás

• Még nem toboroz

  Tenecteplase for the treatment of acute stroke in the late time window before inter-hospital transfer for thrombectomy: a randomized controlled trial

  2026-525280-40-00· 3. fázis· Fondation A De Rothschild· Forrás

• Toboroz

  ODSSEY-SCD_Identification Of Markers to preDict the rISk of Sudden Cardiac Death in Moderated LVEF in ischEmic cardiomyopathY

  NCT07545512· University Hospital, Clermont-Ferrand· Forrás

• Toboroz

  A Phase 3 Study Comparing Ramantamig plus Daratumumab Versus DVRd or DRd in Participants With NDMM for Whom Hematopoietic Stem Cell Transplant is Not Planned as Initial Therapy

  2026-526654-14-01· 3. fázis· Janssen Cilag International· Forrás

• Toboroz

  ROSY-F: Roll-over Study for Participants Who Have Completed a Previous Clinical Study with Benralizumab (Fasenra) and Benefit from Continued Treatment

  2025-523307-29-00· 3. fázis· AstraZeneca AB· Forrás

• Toboroz

  Evaluating Aganirsen Eye Drops to Reduce the Number of Aflibercept Injections in Wet Age-Related Macular Degeneration Patients.

  2026-526775-27-00· 2. fázis· Laboratoires Kol· Forrás

• Még nem toboroz

  A Study to Evaluate S241656 Alone or in Combination in Participants With Selected Myeloid Malignancies

  NCT07719348· 1/2. fázis· Servier· Forrás

• Még nem toboroz

  Treatment in Patients With Advanced Non-Small Cell Lung Carcinoma and Interstitial Lung Disease

  NCT07420439· 2. fázis· Intergroupe Francophone de Cancerologie Thoracique· Forrás

• Toboroz

  Feasibility of the Application of a new Six-month Treatment for multidrug-resistant tuberculosis (MDR-TB) patients in France (FAST-MDR)

  2024-512763-32-00· 3. fázis· Assistance Publique Hopitaux De Paris· Forrás

• Toboroz

  A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib

  NCT07623161· 3. fázis· Takeda· Forrás

• Toboroz

  A Randomized, Double-Blind, Phase 3 Study of Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D–Mutated Metastatic Pancreatic Ductal Adenocarcinoma (DAWN-303)

  2025-525009-18-00· 3. fázis· Incyte Corp.· Forrás

• Még nem toboroz

  Obinutuzumab for Systemic Lupus Erythematosus Pure Membranous Nephropathy: a Phase II Trial

  NCT07721363· 2. fázis· Assistance Publique - Hôpitaux de Paris· Forrás

• Még nem toboroz

  Creation of a Biological Collection of BRonchiaI and Pulmonary Tissues From Surgical wastE

  NCT07780630· University Hospital, Bordeaux· Forrás

• Még nem toboroz

  OBINUSS - A trial to evaluate a new drug in systemic sclerosis: obinutuzumab.

  2025-524003-68-00· 2. fázis· Assistance Publique Hopitaux De Paris· Forrás

Showing 50 of 774.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Gyermekkori daganatok56 toboroz
• Tüdőrák47 toboroz
• Akut mieloid leukémia (AML)25 toboroz
• Stroke (szélütés)25 toboroz
• Máj- és epeúti rák24 toboroz
• Vastagbélrák24 toboroz
• Akut limfoid leukémia (ALL)18 toboroz
• Mielodiszplasztikus szindróma (MDS)16 toboroz
• Vesedaganat15 toboroz
• Hólyagrák14 toboroz
• Lupus (SLE)13 toboroz
• Mielóma multiplex13 toboroz
• Mieloproliferatív neopláziák13 toboroz
• Hasnyálmirigyrák12 toboroz
• Magas vérnyomás12 toboroz
• Sclerosis multiplex (SM)12 toboroz
• Crohn-betegség11 toboroz
• Krónikus obstruktív tüdőbetegség (COPD)11 toboroz
• Zsírmáj (MASLD/MASH)11 toboroz
• Fej-nyaki daganatok9 toboroz
• Melanóma9 toboroz
• Szisztémás szklerózis (szkleroderma)9 toboroz
• Rheumatoid arthritis8 toboroz
• Colitis ulcerosa7 toboroz
• Diffúz nagy B-sejtes limfóma (DLBCL)7 toboroz
• Gyomor- és nyelőcsőrák7 toboroz
• Immune thrombocytopenia (ITP)7 toboroz
• Narcolepsy7 toboroz
• Neuroendokrin daganatok7 toboroz
• Szívelégtelenség7 toboroz
• Elhízás6 toboroz
• Epilepszia6 toboroz
• Follikuláris limfóma6 toboroz
• Krónikus limfoid leukémia (CLL)6 toboroz
• Krónikus vesebetegség6 toboroz
• Pitvarfibrilláció6 toboroz
• Prosztatarák6 toboroz
• Asztma5 toboroz
• Brain aneurysm5 toboroz
• HIV-fertőzés5 toboroz
• Idiopátiás tüdőfibrózis5 toboroz
• Méhtestrák5 toboroz
• Parkinson-kór5 toboroz
• Sarlósejtes vérszegénység5 toboroz
• Sjögren-szindróma5 toboroz
• Szarkóma5 toboroz
• ANCA-asszociált vasculitis4 toboroz
• Bronchiectasis4 toboroz
• Cisztás fibrózis4 toboroz
• Congenital heart disease4 toboroz
• Dermatomyositis and polymyositis (myositis)4 toboroz
• Hodgkin-limfóma4 toboroz
• Krónikus gyulladásos demielinizációs polineuropátia (CIDP)4 toboroz
• Petefészekrák4 toboroz
• Pulmonális artériás hipertónia4 toboroz
• Alzheimer-kór3 toboroz
• Aortic stenosis3 toboroz
• Cushing's syndrome3 toboroz
• Glioblasztóma3 toboroz
• IgA-nefropátia3 toboroz
• Köpenysejtes limfóma3 toboroz
• Koszorúér-betegség3 toboroz
• Krónikus mieloid leukémia (CML)3 toboroz
• Méhnyakrák3 toboroz
• Mezotelióma3 toboroz
• Myasthenia gravis3 toboroz
• Neuroblasztóma3 toboroz
• Neuromyelitis optica (NMOSD)3 toboroz
• Obstructive sleep apnoea3 toboroz
• Ventricular tachycardia3 toboroz
• Vitiligo3 toboroz
• 1-es típusú cukorbetegség2 toboroz
• 2-es típusú cukorbetegség2 toboroz
• Amiloidózis2 toboroz
• Aplastic anaemia2 toboroz
• Áttétes emlőrák2 toboroz
• Cytomegalovirus infection2 toboroz
• Gout2 toboroz
• Hidradenitis suppurativa2 toboroz
• Huntington-kór2 toboroz
• Időskori makuladegeneráció2 toboroz
• Liver cirrhosis2 toboroz
• Multiple system atrophy2 toboroz
• Osteoarthritis2 toboroz
• Peripheral artery disease2 toboroz
• Sarcoidosis2 toboroz
• Amiotrófiás laterálszklerózis (ALS)1 toboroz
• Atópiás dermatitisz (ekcéma)1 toboroz
• Autizmus spektrumzavar1 toboroz
• Barrett's oesophagus1 toboroz
• Csontritkulás1 toboroz
• Down syndrome1 toboroz
• Duchenne-izomdisztrófia1 toboroz
• Endometriózis1 toboroz
• Fabry-betegség1 toboroz
• Hemofília1 toboroz
• Hepatitis B (krónikus)1 toboroz
• Hepatitis C1 toboroz
• Hipertrófiás kardiomiopátia1 toboroz
• Irritable bowel syndrome1 toboroz
• Meningioma1 toboroz
• Myocarditis1 toboroz
• Primer biliáris cholangitis (PBC)1 toboroz
• Spinal cord injury1 toboroz
• Spondylitis ankylopoetica (Bechterew-kór)1 toboroz
• Tourette syndrome1 toboroz
• Tripla negatív emlőrák1 toboroz
• Tuberkulózis1 toboroz
• Zöldhályog (glaukóma)1 toboroz

Lezárt vizsgálatok

• Még nem toboroz

  Phase 2 Trial of TAK-755 for Acute Ischemic Stroke

  2025-522734-31-00· 2. fázis· Takeda Development Center Americas Inc.· Forrás

• Lezárult

  A Phase 2 Study of Petosemtamab in Combination with Pembrolizumab in Adults with NSCLC

  2025-522867-13-00· 2. fázis· Merus B.V.· Forrás

• Toboroz

  A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

  NCT07226843· 1. fázis· Eli Lilly and Company· Forrás

• Lezárult

  PRODIGE 111 – DOMZIGAST A randomized phase II study evaluating FOLFIRI vs FOLFIRI plus Domvanalimab (anti-TIGIT) and Zimberelimab (anti-PD1) in patients with advanced gastric or gastro-oesophageal junction adenocarcinoma with progression during or after peri-operative chemotherapy.

  2024-519258-35-00· 2. fázis· Fondation Franc.Cancerologie Digestive· Forrás

• Lezárult

  Study of the Effectiveness and Safety of Acasunlimab Alone or With Pembrolizumab in treating Advanced Melanoma of the Skin That Has Returned After or did not respond to Cancer Immunotherapy (ABBIL1TY MELANOMA-07)

  NCT06984328· 2. fázis· Genmab A/S· Forrás

• Toboroz

  Dose Range Finding, Efficacy, and Safety Study of Nebulized CSL787 in Adults With Non-cystic Fibrosis Bronchiectasis (NCFB)

  NCT07048262· 2. fázis· CSL Behring· Forrás

• Lezárult

  A Study to see How Well and How Safely Different Treatments Work in a Group of Patients with Non-Small Cell Lung Cancer, Chosen Based on their Biomarker Status

  2024-511239-91-00· 2. fázis· F. Hoffmann-La Roche AG· Forrás

• Lezárult

  A trial to learn how well benralizumab works and how safe it is when given in addition to standard asthma treatments in people with eosinophilic asthma

  2024-515162-13-00· 3. fázis· AstraZeneca AB· Forrás

• Toboroz

  A Randomized, Double-Blind, Placebo-Controlled, MultiRegional Phase III Clinical Study of Toripalimab Alone or in Combination With Tifcemalimab (JS004/TAB004) as Consolidation Therapy in Patients With Limited-Stage Small Cell Lung Cancer Without Disease Progression Following Chemoradiotherapy

  2023-507097-41-01· 3. fázis· Shanghai Junshi Biosciences Co. Ltd.· Forrás

• Fut, nem toboroz

  A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer

  NCT06521567· 1/2. fázis· GlaxoSmithKline· Forrás

• Lezárult

  A study to evaluate S227928 as a Single Agent and in Combination with Venetoclax in Patients with R/R AML, MDS/AML, or CMML

  NCT06563804· 1/2. fázis· Institut De Recherches Internationales Servier IRIS· Forrás

• Fut, nem toboroz

  A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis

  NCT06744920· 3. fázis· Novartis Pharmaceuticals· Forrás

• Lezárult

  N/A

  2024-513121-22-00· 2. fázis· Gilead Sciences Inc.· Forrás

• Lezárult

  A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral Neuropathy

  NCT06797869· 2. fázis· Novo Nordisk A/S· Forrás

• Lezárult

  Long-term Outcomes of Glaucoma Surgery in a Real-life Setting: the Agora Registry Study

  NCT06829810· University Hospital, Bordeaux· Forrás

• Visszavonták

  Towards Optimal Screening and Management of Coronary Artery Disease in Diabetes: TOSCANA Study

  NCT05314140· French Cardiology Society· Forrás

• Lezárult

  Translation and Validation of the French Version of the Sleep Regularity Questionnaire: a New Tool to Address the the Challenge of Sleep Health

  NCT06727448· University Hospital, Bordeaux· Forrás

• Lezárult

  Study of Oral Weekly GS-1720 and GS-4182 Versus Biktarvy in People With HIV-1 Who Are Virologically Suppressed

  NCT06544733· 2/3. fázis· Gilead Sciences Inc.· Forrás

• Lezárult

  A Phase 2 Study to Investigate Efficacy and Safety of HZN-1116 in Participants With Sjögren’s Syndrome

  NCT06312020· 2. fázis· Horizon Therapeutics Ireland Designated Activity Company· Forrás

• Fut, nem toboroz

  A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)

  NCT06422884· 2. fázis· Endeavor Biomedicines, Inc.· Forrás

• Lezárult

  A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (PAH) (MK-7962-024)

  NCT06664801· 2. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  Exploring Long-term Risks and STI Prevalence in Pre-Exposure Prophylaxis Users in Gironde, France

  NCT06600087· University Hospital, Bordeaux· Forrás

• Lezárult

  A study to investigate the safety and pharmacological effect of a single intravenous infusion of GSK2857914 in male and female participants aged 18 to 75 with moderate to severe systemic lupus erythematosus

  NCT06413511· 1. fázis· Glaxosmithkline Research & Development Limited· Forrás

• Lezárult

  ALS Phase II Study of NX210c

  NCT06365216· 2. fázis· Axoltis Pharma· Forrás

• Lezárult

  A Study of TAK-861 in People With Narcolepsy Type 1

  NCT06505031· 3. fázis· Takeda· Forrás

• Lezárult

  Pilot study, open label, multicenter, evaluating dual antiretroviral therapy with long-acting cabotegravir/lenacapavir IMEA 069 - CALENDULA

  2024-516028-33-01· 3. fázis· Inst Medecine Epidemiologie Appliquee· Forrás

• Lezárult

  A Clinical Study of Mitapivat in Patients with Sickle Cell Disease and Kidney Disease

  NCT06286046· 2. fázis· Agios Pharmaceuticals Inc.· Forrás

• Lezárult

  Phase 2 study to evaluate the efficacy and safety of GSK3915393 in participants with Idiopathic Pulmonary Fibrosis (IPF)

  NCT06317285· 2. fázis· Glaxosmithkline Research & Development Limited· Forrás

• Lezárult

  A study to test whether BI 1839100 improves cough in people with idiopathic pulmonary fibrosis or progressive pulmonary fibrosis

  2023-510249-79-00· 2. fázis· Boehringer Ingelheim International GmbH· Forrás

• Fut, nem toboroz

  RVU120 for Treatment of Anemia in Patients With Lower-risk Myelodysplastic Neoplasms

  NCT06243458· 2. fázis· GCP-Service International West GmbH· Forrás

• Lezárult

  A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 2

  NCT06555783· 2. fázis· Alkermes, Inc.· Forrás

• Lezárult

  A study to find how well Dazodalibep works and how safe it is in participants with Sjögren’s Syndrome

  2023-503923-24-00· 3. fázis· Horizon Therapeutics Ireland Designated Activity Company· Forrás

• Lezárult

  A randomized, double-blind, dose-ranging, placebo-controlled study to evaluate the efficacy and safety of PLN-74809 (bexotegrast) for the treatment of idiopathic pulmonary fibrosis (BEACON-IPF)

  2023-506185-31-00· 2/3. fázis· Pliant Therapeutics Inc.· Forrás

• Fut, nem toboroz

  A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)

  NCT06456580· 3. fázis· Vor Biopharma· Forrás

• Lezárult

  A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017)

  NCT06465186· 2. fázis· Merck Sharp & Dohme LLC· Forrás

• Fut, nem toboroz

  Lenvatinib Treatment in Waiting List of Liver Transplantation After TACE Failure in Patients With Hepatocellular Carcinoma

  NCT05901194· 1/2. fázis· Assistance Publique - Hôpitaux de Paris· Forrás

• Lezárult

  Open-label Extension of Vericiguat in Pediatric Participants with Heart Failure due to Left Ventricular Systolic Dysfunction

  2023-506210-40-00· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  A Phase 3 Double-masked, Randomized, Multicenter Study of the Efficacy and Safety of OCS-01 Eye Drops in Subjects With Diabetic Macular Edema

  2023-507207-66-00· 3. fázis· Oculis Operations S.a.r.l.· Forrás

• Lezárult

  Glenzocimab in Anterior stroke with Large Ischemic Core eligible for Endovascular therapy

  2023-509615-92-00· 2. fázis· Hopital Fondation Adolphe De Rothschild· Forrás

• Fut, nem toboroz

  A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2)

  NCT06346067· 3. fázis· Erasca, Inc.· Forrás

• Lezárult

  A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 1 (ALKS 2680-201)

  NCT06358950· 2. fázis· Alkermes, Inc.· Forrás

• Lezárult

  FIH study of ALE.C04 anti-CLDN1 mAb monotherapy or in combination with pembrolizumab in patients with R/M HNSCC

  2023-505145-93-00· 1/2. fázis· Alentis Therapeutics AG· Forrás

• Lezárult

  A clinical study of MK-6194 for the treatment of Systemic Lupus Erythematosus (SLE) (MK-6194-006)

  2023-505520-61-00· 2/3. fázis· Merck Sharp & Dohme LLC· Forrás

• Fut, nem toboroz

  A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor

  NCT06241118· 3. fázis· Sanofi· Forrás

• Toboroz

  Efficacy and Safety of Methotrexate Versus Placebo in Adults With Atopic Dermatitis.

  NCT06239311· 3. fázis· medac GmbH· Forrás

• Fut, nem toboroz

  A Phase 2 Study to Evaluate DNTH103 in Adults With Generalized Myasthenia Gravis (MAGIC)

  NCT06282159· 2. fázis· Dianthus Therapeutics· Forrás

• Lezárult

  A trial to find out if vidutolimod together with cemiplimab is safe and if it works in adult participants with advanced cancer or metastatic cancer

  NCT04916002· 2. fázis· Regeneron Pharmaceuticals Inc.· Forrás

• Lezárult

  A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity

  NCT06104124· 3. fázis· Amgen· Forrás

• Fut, nem toboroz

  Phase 2 Platform Study of Novel Immunotherapy Combinations as First-Line Treatment in Participants with PD-L1 Positive Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck

  2023-503428-24-00· 2. fázis· Glaxosmithkline Research & Development Limited· Forrás

• Lezárult

  A Study to Investigate Long-term Safety and Tolerability of Itepekimab in Participants With COPD

  NCT06208306· 3. fázis· Sanofi· Forrás

Showing 50 of 300.

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Pitvarfibrilláció56 munka · 12 vizsgálat
• Szisztémás szklerózis (szkleroderma)38 munka · 21 vizsgálat
• Akut mieloid leukémia (AML)32 munka · 56 vizsgálat
• Mielóma multiplex23 munka · 42 vizsgálat
• Crohn-betegség23 munka · 17 vizsgálat
• Vesedaganat22 munka · 32 vizsgálat
• Congenital heart disease22 munka · 5 vizsgálat
• Cisztás fibrózis20 munka · 9 vizsgálat
• Időskori makuladegeneráció17 munka · 5 vizsgálat
• Ventricular tachycardia16 munka · 4 vizsgálat
• Atópiás dermatitisz (ekcéma)16 munka · 13 vizsgálat
• Pulmonális artériás hipertónia15 munka · 9 vizsgálat
• Hodgkin-limfóma14 munka · 11 vizsgálat
• Multiple system atrophy11 munka · 7 vizsgálat
• Mielodiszplasztikus szindróma (MDS)11 munka · 34 vizsgálat
• Vitiligo10 munka · 13 vizsgálat
• Bronchiectasis10 munka · 5 vizsgálat
• Cushing's syndrome9 munka · 4 vizsgálat
• Cytomegalovirus infection8 munka · 2 vizsgálat
• Köpenysejtes limfóma8 munka · 9 vizsgálat
• Hemofília6 munka · 7 vizsgálat
• Dystonia6 munka · 0 vizsgálat
• Dermatomyositis and polymyositis (myositis)5 munka · 6 vizsgálat
• Krónikus mieloid leukémia (CML)5 munka · 7 vizsgálat
• ANCA-asszociált vasculitis5 munka · 8 vizsgálat
• Follikuláris limfóma5 munka · 15 vizsgálat
• Sjögren-szindróma4 munka · 13 vizsgálat
• Aplastic anaemia4 munka · 2 vizsgálat